ENERGI-F705PD

N/A

Report date: 2025/07/08 16:57:09
NMEFirst In Class

Base Information

Drug NameENERGI-F705PD
Drug Alias NameENERGI-F705PD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATPase stimulants
TargetsATPase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnergenesis Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A